Prosperitas Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.97M Sell
4,312
-106
-2% -$107K 1.48% 29
2025
Q4
$4.75M Buy
4,418
+153
+4% +$146K 1.85% 18
2025
Q3
$3.25M Buy
4,265
+359
+9% +$267K 1.35% 30
2025
Q2
$3.05M Buy
3,906
+410
+12% +$319K 1.43% 28
2025
Q1
$2.89M Buy
3,496
+247
+8% +$206K 1.49% 24
2024
Q4
$2.51M Buy
3,249
+160
+5% +$132K 1.27% 31
2024
Q3
$2.74M Buy
3,089
+191
+7% +$172K 1.47% 20
2024
Q2
$2.62M Sell
2,898
-35
-1% -$28K 1.6% 19
2024
Q1
$2.28M Buy
2,933
+300
+11% +$214K 1.46% 22
2023
Q4
$1.53M Sell
2,633
-93
-3% -$54.3K 1.13% 29
2023
Q3
$1.46M Buy
+2,726
New +$1.4M 1.14% 23

Other funds holding LLY

Prosperitas Financial's LLY Position: Q1 2026 in Review

Prosperitas Financial reduced its Eli Lilly (LLY) stake by 2.4% in Q1 2026, selling an estimated $107K and leaving 4,312 shares worth $3.97M. The position accounts for 1.48% of the portfolio, ranked #29.

Prosperitas Financial first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.75M in Q4 2025. 4,366 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Prosperitas Financial held 4,312 shares of Eli Lilly worth $3.97M as of Q1 2026.
  • Prosperitas Financial sold 106 Eli Lilly shares in Q1 2026, an estimated $107K.
  • Eli Lilly made up 1.48% of Prosperitas Financial's portfolio in Q1 2026, its #29 holding.
  • Prosperitas Financial first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Prosperitas Financial's Eli Lilly position peaked at $4.75M in Q4 2025.
  • 4,366 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Prosperitas Financial's 13F filing for Q1 2026, filed 15 May 2026.